Corteva’s (CTVA) Buy Rating Reiterated at Argus

Argus reissued their buy rating on shares of Corteva (NYSE:CTVA) in a report released on Friday,Benzinga reports. The firm currently has a $91.00 target price on the stock.

CTVA has been the subject of a number of other reports. Citigroup lifted their price target on shares of Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a research report on Thursday. UBS Group lifted their target price on shares of Corteva from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday. KeyCorp assumed coverage on Corteva in a research report on Thursday. They issued a “sector weight” rating on the stock. Morgan Stanley raised their price target on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Finally, Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $91.90.

Corteva Price Performance

NYSE:CTVA opened at $80.48 on Friday. Corteva has a 52 week low of $60.53 and a 52 week high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $53.69 billion, a P/E ratio of 53.30, a P/E/G ratio of 2.47 and a beta of 0.57. The stock’s fifty day moving average is $83.12 and its two-hundred day moving average is $81.46.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the business posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts expect that Corteva will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Institutional Trading of Corteva

Several hedge funds have recently modified their holdings of CTVA. Parkside Financial Bank & Trust raised its holdings in shares of Corteva by 3.2% in the second quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock valued at $316,000 after purchasing an additional 116 shares during the last quarter. William B. Walkup & Associates Inc. grew its position in Corteva by 2.9% in the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after purchasing an additional 126 shares in the last quarter. HB Wealth Management LLC increased its stake in Corteva by 0.5% in the 2nd quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock valued at $2,018,000 after buying an additional 128 shares during the last quarter. Wilkerson Advisory Group LLC lifted its position in Corteva by 6.7% during the 1st quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after buying an additional 133 shares in the last quarter. Finally, AdvisorNet Financial Inc lifted its position in Corteva by 2.4% during the 1st quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after buying an additional 135 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.